• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数值方法在人骨髓间充质干细胞体外扩增工艺设计与描述中的应用。

Numerical Methods for the Design and Description of In Vitro Expansion Processes of Human Mesenchymal Stem Cells.

机构信息

Zurich University of Applied Sciences - Institute of Chemistry and Biotechnology, Wädenswil, Switzerland.

出版信息

Adv Biochem Eng Biotechnol. 2021;177:185-228. doi: 10.1007/10_2020_147.

DOI:10.1007/10_2020_147
PMID:33090237
Abstract

Human mesenchymal stem cells (hMSCs) are a valuable source of cells for clinical applications (e.g., treatment of acute myocardial infarction or inflammatory diseases), especially in the field of regenerative medicine. However, for autologous (patient-specific) and allogeneic (off-the-shelf) hMSC-based therapies, in vitro expansion is necessary prior to the clinical application in order to achieve the required cell numbers. Safe, reproducible, and economic in vitro expansion of hMSCs for autologous and allogeneic therapies can be problematic because the cell material is restricted and the cells are sensitive to environmental changes. It is beneficial to collect detailed information on the hydrodynamic conditions and cell growth behavior in a bioreactor system, in order to develop a so called "Digital Twin" of the cultivation system and expansion process. Numerical methods, such as Computational Fluid Dynamics (CFD) which has become widely used in the biotech industry for studying local characteristics within bioreactors or kinetic growth modelling, provide possible solutions for such tasks.In this review, we will present the current state-of-the-art for the in vitro expansion of hMSCs. Different numerical tools, including numerical fluid flow simulations and cell growth modelling approaches for hMSCs, will be presented. In addition, a case study demonstrating the applicability of CFD and kinetic growth modelling for the development of an microcarrier-based hMSC process will be shown.

摘要

人骨髓间充质干细胞(hMSCs)是临床应用(例如,急性心肌梗死或炎症性疾病的治疗)的宝贵细胞来源,特别是在再生医学领域。然而,对于自体(患者特异性)和同种异体(现成)基于 hMSC 的治疗,在临床应用之前需要进行体外扩增,以达到所需的细胞数量。安全、可重复和经济的自体和同种异体 hMSC 体外扩增可能会出现问题,因为细胞材料受到限制,并且细胞对环境变化敏感。收集关于生物反应器系统中流体动力学条件和细胞生长行为的详细信息是有益的,以便开发培养系统和扩增过程的所谓“数字孪生体”。数值方法,如计算流体动力学(CFD),已在生物技术行业中广泛用于研究生物反应器内的局部特征或动力学生长建模,为这些任务提供了可能的解决方案。在这篇综述中,我们将介绍 hMSC 体外扩增的最新技术。将介绍不同的数值工具,包括用于 hMSCs 的数值流体流动模拟和细胞生长建模方法。此外,还将展示一个案例研究,展示 CFD 和动力学生长建模在开发基于微载体的 hMSC 工艺中的适用性。

相似文献

1
Numerical Methods for the Design and Description of In Vitro Expansion Processes of Human Mesenchymal Stem Cells.数值方法在人骨髓间充质干细胞体外扩增工艺设计与描述中的应用。
Adv Biochem Eng Biotechnol. 2021;177:185-228. doi: 10.1007/10_2020_147.
2
Dispersible and Dissolvable Porous Microcarrier Tablets Enable Efficient Large-Scale Human Mesenchymal Stem Cell Expansion.可分散和可溶解多孔微载体片使高效大规模扩增人骨髓间充质干细胞成为可能。
Tissue Eng Part C Methods. 2020 May;26(5):263-275. doi: 10.1089/ten.TEC.2020.0039. Epub 2020 May 11.
3
Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds.微载体在生物反应器中扩增人间质干细胞(hMSCs):经验教训和未来展望。
Biotechnol Adv. 2020 Dec;45:107636. doi: 10.1016/j.biotechadv.2020.107636. Epub 2020 Sep 25.
4
Scaling up human mesenchymal stem cell manufacturing using bioreactors for clinical uses.使用生物反应器扩大用于临床用途的人类间充质干细胞的制造。
Curr Res Transl Med. 2023 Apr-Jun;71(2):103393. doi: 10.1016/j.retram.2023.103393. Epub 2023 Apr 28.
5
An Approach towards a GMP Compliant In-Vitro Expansion of Human Adipose Stem Cells for Autologous Therapies.一种用于自体治疗的符合GMP标准的人脂肪干细胞体外扩增方法。
Bioengineering (Basel). 2020 Jul 20;7(3):77. doi: 10.3390/bioengineering7030077.
6
Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges.临床规模制造人间质干细胞:工艺和监管挑战。
Appl Microbiol Biotechnol. 2018 May;102(9):3981-3994. doi: 10.1007/s00253-018-8912-x. Epub 2018 Mar 22.
7
Large-Scale Automated Hollow-Fiber Bioreactor Expansion of Umbilical Cord-Derived Human Mesenchymal Stromal Cells for Neurological Disorders.大规模自动化中空纤维生物反应器扩增脐带源人基质干细胞用于神经疾病。
Neurochem Res. 2020 Jan;45(1):204-214. doi: 10.1007/s11064-019-02925-y. Epub 2019 Dec 11.
8
Expansion of Human Mesenchymal Stem Cells in a Microcarrier Bioreactor.人骨髓间充质干细胞在微载体生物反应器中的扩增
Methods Mol Biol. 2016;1502:77-86. doi: 10.1007/7651_2016_338.
9
Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes.在一次性垂直轮生物反应器系统中生产溶瘤腺病毒和人间充质干细胞:生物反应器设计对基于微载体的细胞培养过程性能的影响。
Biotechnol Prog. 2015 Nov-Dec;31(6):1600-12. doi: 10.1002/btpr.2158. Epub 2015 Sep 4.
10
Growth Behavior of Human Adipose Tissue-Derived Stromal/Stem Cells at Small Scale: Numerical and Experimental Investigations.人脂肪组织来源的基质/干细胞在小规模下的生长行为:数值与实验研究
Bioengineering (Basel). 2018 Dec 4;5(4):106. doi: 10.3390/bioengineering5040106.

引用本文的文献

1
Improvement of HEK293 Cell Growth by Adapting Hydrodynamic Stress and Predicting Cell Aggregate Size Distribution.通过适应流体动力应力和预测细胞聚集体大小分布改善HEK293细胞生长
Bioengineering (Basel). 2023 Apr 16;10(4):478. doi: 10.3390/bioengineering10040478.

本文引用的文献

1
Expansion processes for cell-based therapies.细胞治疗的扩展过程。
Biotechnol Adv. 2019 Dec;37(8):107455. doi: 10.1016/j.biotechadv.2019.107455. Epub 2019 Oct 17.
2
Preparing for cell culture scale-out: establishing parity of bioreactor- and flask-expanded mesenchymal stromal cell cultures.为细胞培养扩大规模做准备:建立生物反应器和摇瓶扩增的间充质基质细胞培养物的一致性。
J Transl Med. 2019 Jul 24;17(1):241. doi: 10.1186/s12967-019-1989-x.
3
Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges.
临床规模制造人间质干细胞:工艺和监管挑战。
Appl Microbiol Biotechnol. 2018 May;102(9):3981-3994. doi: 10.1007/s00253-018-8912-x. Epub 2018 Mar 22.
4
A roadmap for cost-of-goods planning to guide economic production of cell therapy products.指导细胞治疗产品经济生产的成本核算规划路线图。
Cytotherapy. 2017 Dec;19(12):1383-1391. doi: 10.1016/j.jcyt.2017.06.009. Epub 2017 Sep 19.
5
Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor.使用自动化高通量微生物反应器进行人多能间充质基质细胞微载体培养的工艺开发
Biotechnol Bioeng. 2017 Oct;114(10):2253-2266. doi: 10.1002/bit.26359. Epub 2017 Jul 27.
6
Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.基于微载体的平台,用于在生物反应器培养系统中对人多能干细胞进行体外扩增和分化。
J Biotechnol. 2016 Sep 20;234:71-82. doi: 10.1016/j.jbiotec.2016.07.023. Epub 2016 Jul 29.
7
Scalability and process transfer of mesenchymal stromal cell production from monolayer to microcarrier culture using human platelet lysate.使用人血小板裂解液将间充质基质细胞从单层培养到微载体培养的可扩展性和工艺转移。
Cytotherapy. 2016 Apr;18(4):523-35. doi: 10.1016/j.jcyt.2016.01.007.
8
Physiologically Low Oxygen Enhances Biomolecule Production and Stemness of Mesenchymal Stem Cell Spheroids.生理低氧增强间充质干细胞球状体的生物分子产生及干性。
Tissue Eng Part C Methods. 2016 Apr;22(4):360-9. doi: 10.1089/ten.TEC.2015.0465.
9
Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors.系统的微载体筛选和搅拌培养条件可提高生物反应器中人间充质干细胞的产量。
Biotechnol J. 2016 Mar;11(4):473-86. doi: 10.1002/biot.201400862. Epub 2016 Feb 29.
10
Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review.用于大规模生产人间充质干细胞的生物加工策略:综述
Stem Cell Res Ther. 2015 Nov 23;6:225. doi: 10.1186/s13287-015-0228-5.